View Post

Breakthrough immunotherapy targets non-cancer cells to prevent breast cancer spread

In In The News by Barbara Jacoby

Source: Breast Cancer Now From: news-medical.net A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer tumors, according to new research funded by Breast Cancer Now. The discovery, published today (28 February) in The Journal for ImmunoTherapy of Cancer, has found that an immunotherapy approach targeting a protein called endosialin disrupts …

View Post

Researchers Discover Breakthrough in Immunotherapy’s Side Effects

In In The News by Barbara Jacoby

From: breastadvocateapp.com Researchers at the University of Michigan Health Rogel Cancer Center have made a significant breakthrough in understanding and mitigating severe gastrointestinal problems associated with immune-based cancer treatment. This discovery could lead to more effective cancer therapies with fewer adverse effects. Immunotherapy’s Promise and Pitfalls Immunotherapy has gained prominence as a promising approach for treating various types of cancer. …

View Post

Combination Radiation with Immunotherapy Shows Promise Against “Cold” Breast Cancer Tumors

In In The News by Barbara Jacoby

From: news.weill.cornell.edu Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models of triple negative breast cancer, a cancer type that’s typically resistant to immunotherapy alone. Immunotherapy activates the body’s own immune system to fight cancer but isn’t effective …

View Post

Revolutionary New Technology Predicts Cancer Patients’ Response to Immunotherapy

In In The News by Barbara Jacoby

From: prnewswire.com A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, with significantly greater accuracy than current methods. The study’s results were published late last week in the prestigious journal Science Advances. The study was led by Bar …

View Post

Immunotherapy to shrink treatment-resistant cancer tumors

In In The News by Barbara Jacoby

By: Pai Liu, Michigan State University From: medicalxpress.com Advancements in cancer research and treatment have resulted in great improvements in survival rates—today, there are almost 17 million people in the United States alone who have survived their diagnosis because of the physicians and scientists who have dedicated their careers to breakthrough approaches. June is Cancer Survivor Month, and as we …

View Post

Radical increase in the effectiveness of breast cancer immunotherapy

In In The News by Barbara Jacoby

By: IMIM (Hospital del Mar Medical Research Institute) From: medicalxpress.com A study published in the journal Nature Cancer, carried out within the Cancer Program at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, led by Dr. Toni Celià-Terrassa, and the Laboratory of Molecular Cancer Therapy, coordinated by Dr. Joan …

View Post

NIH study advances personalized immunotherapy for metastatic breast cancer

In In The News by Barbara Jacoby

From: nih.gov An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according to results from an ongoing clinical trial led by researchers at the National Cancer Institute’s (NCI) Center for Cancer Research, part of the National Institutes of Health. Many people with metastatic breast cancer …

View Post

Study: Protein may predict response to immunotherapy in breast cancer

In Clinical Studies News by Barbara Jacoby

By: Brian P. Dunleavy The presence of a specific molecule in breast cancer tumors may serve as an indicator of potential response to treatment with immunotherapy drugs, a study published Tuesday by Clinical Cancer Research found. Tumors with the molecule, or Major Histocompatibility Complex Class II protein, are more likely to respond well to immunotherapy, which is designed to boost …

View Post

‘Tumor avatars’ predict patients’ response to immunotherapy

In In The News by Barbara Jacoby

Source: Netherlands Cancer Institute Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. “We’ve solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab”, says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the …

View Post

Natural killers: Using the body’s cells to target breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Clemson Universitty From: medicalxpress.com It sounds like a plot from a Quentin Tarantino movie—something sets off natural killers and sends them on a killing spree. But instead of characters in a movie, these natural killers are part of the human immune system and their targets are breast cancer tumor cells. The triggers are fusion proteins developed by Clemson University …